NCT02682667
- Conditions
- Blood Protein Disorders, Bronchial Neoplasms, Carcinoma, Bronchogenic, +31 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Clinical trial condition
Leukemia-Lymphoma, Adult T-Cell
Explore clinical trials studying Leukemia-Lymphoma, Adult T-Cell. Study availability and eligibility vary by location and protocol.
25 public trials
5 recruiting studies
Leukemia-Lymphoma, Adult T-Cell trial results
NCT01676805
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +23 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
- University of the West Indies Kingston, Jamaica
Recruiting
Dolutegravir Versus Dolutegravir in Combination With Tenofovir for the Treatment of HTLV-1 Infection
NCT07555431
- Conditions
- Central Nervous System Diseases, Central Nervous System Infections, Deltaretrovirus Infections, +29 more
- Locations
-
- Hospital Universitário Professor Edgard Santos Salvador, Estado de Bahia, Brazil
Recruiting
Clinical Trial of CD5-targeted CAR-NK Therapy for Relapse/Refractory T-Cell Hematologic Malignancies
NCT06909474
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
- Locations
-
- Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology Wuhan, Hubei, China
NCT04014374
- Conditions
- ATLL, Cutaneous T Cell Lymphoma, Hematologic Diseases, +16 more
- Locations
-
- CIBMTR Milwaukee, Wisconsin, United States
Active, not recruiting
A Study to Assess the Safety, Tolerability, Efficacy, and Drug Levels of BMS-986369 (Golcadomide) in Participants With Relapsed or Refractory T-cell Lymphomas in Japan (GOLSEEK-3)
NCT06035497
- Conditions
- Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +26 more
- Locations
-
- Local Institution - 0031 Anjo-shi, Aichi-ken, Japan
- Local Institution - 0011 Nagoya, Aichi-ken, Japan
- Local Institution - 0024 Toyohashi, Aichi-ken, Japan
- Local Institution - 0017 Kamogawa, Chiba, Japan
Active, not recruiting
DS-3201b in Participants With Lymphomas
NCT02732275
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +17 more
- Locations
-
- City of Hope National Medical center Duarte, California, United States
- Yale University New Haven, Connecticut, United States
- Emory University Atlanta, Georgia, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
Active, not recruiting
9-ING-41 in Patients With Advanced Cancers
NCT03678883
- Conditions
- Acute T Cell Leukemia Lymphoma, Bone Cancer, Bone Diseases, +90 more
- Locations
-
- Mayo Clinic Phoenix, Arizona, United States
- Arizona Oncology Associates Tucson, Arizona, United States
- The University of Arizona Cancer Center Tucson, Arizona, United States
- University of California Irvine Health Orange, California, United States
NCT02737046
- Conditions
- ATLL, Adult T-Cell Leukemia-Lymphoma, Hematologic Diseases, +11 more
- Locations
-
- University of Miami Miami, Florida, United States
NCT01626664
- Conditions
- Adult T-Cell Leukemia-Lymphoma, Hematologic Diseases, Hemic and Lymphatic Diseases, +12 more
- Locations
-
- Cedars-Sinai Medical Center Los Angeles, California, United States
- University of Miami / Sylvester Comprehensive Cancer Center Miami, Florida, United States
- Northwestern University Chicago, Illinois, United States
- National Cancer Institute Bethesda, Maryland, United States